Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Price (Quote)

$3.04
+0 (+0%)
At Close: Jan 22, 2018

Range Low Price High Price Comment
30 days $2.52 $3.25 Monday, 22nd Jan 2018 ITEK stock ended at $3.04. During the day the stock fluctuated 0% from a day low at $3.04 to a day high of $3.04.
90 days $1.96 $3.25
52 weeks $0.85 $3.80

Historical Inotek Pharmaceuticals Corporation prices

Date Open High Low Close Volume
Jul 25, 2017 $1.00 $1.01 $0.98 $0.99 694 250
Jul 24, 2017 $1.00 $1.01 $0.98 $1.00 961 778
Jul 21, 2017 $1.03 $1.03 $0.96 $1.00 825 699
Jul 20, 2017 $1.00 $1.05 $0.99 $1.03 729 752
Jul 19, 2017 $1.04 $1.04 $1.00 $1.00 594 404
Jul 18, 2017 $1.05 $1.05 $1.01 $1.02 778 143
Jul 17, 2017 $0.97 $1.05 $0.96 $1.05 1 826 239
Jul 14, 2017 $0.90 $0.95 $0.90 $0.93 1 409 316
Jul 13, 2017 $0.92 $0.94 $0.90 $0.90 1 184 382
Jul 12, 2017 $0.93 $0.95 $0.90 $0.94 1 882 248
Jul 11, 2017 $1.02 $1.05 $0.93 $0.96 2 236 620
Jul 10, 2017 $0.95 $1.00 $0.85 $0.95 10 576 615
Jul 07, 2017 $1.75 $1.80 $1.70 $1.73 768 200
Jul 06, 2017 $1.75 $1.80 $1.65 $1.70 1 016 605
Jul 05, 2017 $1.80 $1.83 $1.75 $1.75 1 228 785
Jul 03, 2017 $1.90 $1.93 $1.80 $1.83 374 289
Jun 30, 2017 $1.90 $1.95 $1.85 $1.90 869 580
Jun 29, 2017 $1.85 $1.95 $1.85 $1.90 1 133 803
Jun 28, 2017 $1.95 $2.00 $1.85 $1.85 987 909
Jun 27, 2017 $1.90 $2.00 $1.85 $1.95 1 180 519
Jun 26, 2017 $1.90 $1.95 $1.85 $1.90 607 697
Jun 23, 2017 $1.90 $1.92 $1.80 $1.80 2 019 519
Jun 22, 2017 $1.85 $1.90 $1.83 $1.90 486 327
Jun 21, 2017 $1.85 $1.85 $1.78 $1.83 439 433
Jun 20, 2017 $1.90 $1.90 $1.75 $1.80 1 064 429
Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT